Glioblastoma trials in Switzerland

In Switzerland 22 Also abroad 424

22 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

Phase 1Taking people
Anti-GD2 ADC M3554 in Advanced Solid Tumors
Where
Zurich
Age
18 years and over
People
65 worldwide
Run by
EMD Serono Research & Development Institute, Inc.
See details and how to joinNCT06641908 · EU 2024-513687-26-00
No phaseTaking people
Leica Microsystems Sponsored PMCF Study to Collect and Confirm Clinical Data on the Performance of the GLOW400 Device When Used in Accordance With Its Intended Use
Where
Basel
Age
18 years and over
People
37 worldwide
Run by
Leica Microsystems (Schweiz) AG
See details and how to joinNCT07366892
Phase 2/3Taking people
A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma
Where
Lausanne, Zurich
Age
18 years and over
People
2,250 worldwide
Run by
Global Coalition for Adaptive Research
See details and how to joinNCT03970447 · EU 2024-511452-40-00
Phase 1/2Taking people
A Study of Zedoresertib (Debio 0123) in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Zedoresertib (Debio 0123) in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma
Where
Zurich
Age
18 years and over
People
116 worldwide
Run by
Debiopharm International SA
See details and how to joinNCT05765812 · EU 2022-502156-31-00
Phase 2Taking people
Pharmacoscopy for Patients With Refractory Primary Brain Tumors
Where
Basel, Sankt Gallen, Zurich
Age
18 years and over
People
40
Run by
University of Zurich
See details and how to joinNCT06804655
Phase 2Taking people
Vortioxetine for Newly Diagnosed Glioblastoma
Where
Zurich
Age
18 years and over
People
78
Run by
University of Zurich
See details and how to joinNCT07284628
Phase 1Taking people
ONC206 for Treatment of Newly Diagnosed, Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant CNS Tumors
Where
Zurich
Age
2 years to 21 years
People
208 worldwide
Run by
Sabine Mueller, MD, PhD
See details and how to joinNCT04732065 · EU 2025-521180-13-00
Phase 3Taking people
Lomustine With and Without Reirradiation for First Progression of Glioblastoma: a Randomized Phase III Study
Where
Bellinzona, Zurich
Age
18 years and over
People
411 worldwide
Run by
European Organisation for Research and Treatment of Cancer - EORTC
See details and how to joinNCT05904119 · EU 2023-505267-36-00
No phaseTaking people
LITT for Ultra-early GBM Recurrence
Where
Bern
Age
18 years and over
People
12
Run by
Insel Gruppe AG, University Hospital Bern
See details and how to joinNCT07616986
Phase 2Taking people
Efficacy of the Combination of Trimipramine and Atezolizumab With Bevacizumab in Patients With Recurrent Glioblastoma: a Phase 2 Trial
Where
Aarau, Basel, Bern, Fribourg, Lausanne, Lucerne, Zurich
Age
18 years and over
People
59
Run by
Centre Hospitalier Universitaire Vaudois
See details and how to joinNCT07263438
Phase 2Taking people
Surgery for Recurrent Glioblastoma
Where
Basel, Bern, Lausanne, Lugano
Age
18 years and over
People
120 worldwide
Run by
Insel Gruppe AG, University Hospital Bern
See details and how to joinNCT02394626
No phaseNot yet taking people in Switzerland
A Multicenter, Prospective Study for Glioblastoma Patients
Where
Bern
Age
18 years and over
People
100 worldwide
Run by
Larissa University Hospital
See details and how to joinNCT07162324
No phaseTaking people
Restrictive Use of Dexamethasone in Glioblastoma
Where
Basel, Bern, Sankt Gallen, Zurich
Age
18 years to 90 years
People
50
Run by
Insel Gruppe AG, University Hospital Bern
See details and how to joinNCT04266977
No phaseTaking people
Response Assessment During MR-guided Radiation Therapy for Glioblastoma
Where
Zurich
Age
18 years and over
People
20
Run by
University of Zurich
See details and how to joinNCT05565326
No phaseTaking people
Advanced Diffusion MRI to Differentiate Tumor Recurrence From Pseudoprogression in Patients With Glioblastoma and Brain Metastases
Where
Basel
Age
18 years and over
People
10
Run by
University Hospital, Basel, Switzerland
See details and how to joinNCT05911230
Phase 1/2Taking people
Glutamate Inhibitors in Glioblastoma
Where
Zurich
Age
18 years and over
People
120
Run by
University of Zurich
See details and how to joinNCT05664464
No phaseTaking people
The RECSUR-study: Resection Versus Best Oncological Treatment for Recurrent Glioblastoma (ENCRAM 2302)
Where
Bern
Age
18 years to 90 years
People
464 worldwide
Run by
Jasper Gerritsen
See details and how to joinNCT06283927
No phaseTaking people
The SUPRAMAX Study: Supramaximal Resection Versus Maximal Resection for High-Grade Glioma Patients (ENCRAM 2201)
Where
Bern
Age
18 years to 90 years
People
784 worldwide
Run by
Jasper Gerritsen
See details and how to joinNCT06118723
No phaseTaking people
The RECMAP-study: Resection With or Without Intraoperative Mapping for Recurrent Glioblastoma
Where
Bern
Age
Up to 90 years
People
225 worldwide
Run by
Erasmus Medical Center
See details and how to joinNCT06273176
No phaseTaking people
The RESBIOP-study: Resection Versus Biopsy in High-grade Glioma Patients (ENCRAM 2202)
Where
Bern
Age
18 years to 90 years
People
564 worldwide
Run by
Jasper Gerritsen
See details and how to joinNCT06146725
No phaseTaking people
The PALSUR-study: Palliative Care Versus Surgery in High-grade Glioma Patients (ENCRAM 2203)
Where
Bern
Age
18 years to 90 years
People
1,015 worldwide
Run by
Jasper Gerritsen
See details and how to joinNCT06146738
Phase 1/2Taking people
Safety and Efficacy of L19TNF Plus Temozolomide Chemoradiotherapy in Patients With Newly Diagnosed Glioblastoma
Where
Zurich
Age
18 years and over
People
226 worldwide
Run by
Philogen S.p.A.
See details and how to joinNCT04443010 · EU 2024-516357-46-00